PUBLISHER: Azoth Analytics | PRODUCT CODE: 1319922
PUBLISHER: Azoth Analytics | PRODUCT CODE: 1319922
Azoth Analytics has released a research report titled "Global Obesity Market (2023 Edition)" which provides a complete analysis of the Global Obesity Industry By Drug Type (Appetite Suppressants, Combination Drugs, Malabsorption Drugs, Other Drugs), Age Group (0-18 years, 19-39 years, 40-59 years, Above 60 years), Gender (Male, Female) for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.
The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East and Africa) and 10 countries (United States, Canada, Brazil, United Kingdom, Germany, France, Italy, Spain, China, Japan). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.
The research report also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution.
During the forecast period, 2024-2029, the Global Obesity Market is expected to expand at a CAGR of 14.4%. The rising population, as well as the limited awareness and education about the importance of healthy eating and physical activity, are driving the Global Obesity Market. The Global Obesity Market is expected to generate USD 61.7 billion by the end of 2029, up from USD 25.24 billion in 2022. Changing dietary habits, globalization and food availability, have emerged as key drivers for the global obesity market.
The global obesity epidemic has become one of the most pressing public health challenges of the 21st century. With increasing prevalence rates across all age groups and geographical regions, obesity has significant implications for individuals, healthcare systems, and societies at large. The research study delves into the complexities of the global obesity market, examining the drivers, restraints, and trends shaping the landscape. It also explores innovative solutions and strategies aimed at curbing obesity's rise and fostering a healthier future.
Changing dietary habits have a profound impact on the global obesity market. As people across the world adopt new eating patterns and food choices, the prevalence of obesity and overweight has been on the rise. It often involves the consumption of energy-dense, nutrient-poor foods that are high in calories, sugars, and unhealthy fats. These foods can lead to an energy imbalance, where individuals consume more calories than they expend, resulting in weight gain and obesity.
Changing dietary habits in the Asia Pacific region have had a significant impact on the prevalence of obesity and overweight, leading to an escalating obesity market in the region. As urbanization and globalization continue, traditional dietary practices are sometimes replaced by more convenient and processed food options. This shift can result in a decline in the consumption of nutrient-rich traditional foods, leading to nutritional imbalances.
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: United States Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A3: United States Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A4: United States Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A5: United States Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A6: United States Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A7: United States Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A8: Canada Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A9: Canada Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A10: Canada Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A11: Canada Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A12: Canada Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A13: Canada Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A14: Brazil Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A15: Brazil Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A16: Brazil Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A17: Brazil Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A18: Brazil Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A19: Brazil Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A20: Rest of Americas Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A21: Rest of Americas Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A22: Rest of Americas Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A23: Rest of Americas Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A24: Rest of Americas Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A25: Rest of Americas Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A26: United Kingdom Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A27: United Kingdom Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A28: United Kingdom Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A29: United Kingdom Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A30: United Kingdom Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A31: United Kingdom Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A32: Germany Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A33: Germany Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A34: Germany Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A35: Germany Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A36: Germany Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A37: Germany Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A38: France Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A39: France Obesity Market, By Gender, By Value, 2024-2029(USD Million)
Table A40: France Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A41: France Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A42: France Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A43: France Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A44: Italy Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A45: Italy Obesity Market, By Gender, By Value, 2024-2029(USD Million)
Table A46: Italy Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A47: Italy Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A48: Italy Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A49: Italy Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A50: Spain Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A51: Spain Obesity Market, By Gender, By Value, 2024-2029(USD Million)
Table A52: Spain Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A53: Spain Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A54: Spain Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A55: Spain Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A56: Rest of Europe Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A57: Rest of Europe Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A58: Rest of Europe Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A59: Rest of Europe Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A60: Rest of Europe Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A61: Rest of Europe Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A62: China Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A63: China Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A64: China Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A65: China Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A66: China Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A67: China Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A68: Japan Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A69: Japan Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A70: Japan Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A71: Japan Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A72: Japan Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A73: Japan Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A74: Rest of Asia Pacific Obesity Market, By Gender, By Value, 2019-2022 (USD Million)
Table A75: Rest of Asia Pacific Obesity Market, By Gender, By Value, 2024-2029 (USD Million)
Table A76: Rest of Asia Pacific Obesity Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A77: Rest of Asia Pacific Obesity Market, By Drug Type, By Value, 2024-2029 (USD Million)
Table A78: Rest of Asia Pacific Obesity Market, By Age Group, By Value, 2019-2022 (USD Million)
Table A79: Rest of Asia Pacific Obesity Market, By Age Group, By Value, 2024-2029 (USD Million)
Table A80: Novo Nordisk Key Financials, 2020-2022
Table A81: Eli Lilly and Company Key Financials, 2020-2022
Table A82: Altimmune Revenues, 2020-2022 (USD Million)
Table A83: Amgen Revenues, 2020-2022 (USD Million)
Table A84: Novartis Key Financials, 2020-2022
Table A85: Zealand Pharma Key Financials, 2020-2022
Table A86: AstraZeneca Key Financials, 2020-2022
Table A87: Bristol Myers Squibb Key Financials, 2020-2022